These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33178596)

  • 61. Alternative splicing events are prognostic in hepatocellular carcinoma.
    Chen QF; Li W; Wu P; Shen L; Huang ZL
    Aging (Albany NY); 2019 Jul; 11(13):4720-4735. PubMed ID: 31301224
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comprehensive Characterization of the Prognosis Value of Alternative Splicing Events in Acute Myeloid Leukemia.
    Chen XX; Zhu JH; Li ZP; Xiao HT; Zhou H
    DNA Cell Biol; 2020 Jul; 39(7):1243-1255. PubMed ID: 32543226
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Novel Functional Splice Variant of
    Guo T; Sakai A; Afsari B; Considine M; Danilova L; Favorov AV; Yegnasubramanian S; Kelley DZ; Flam E; Ha PK; Khan Z; Wheelan SJ; Gutkind JS; Fertig EJ; Gaykalova DA; Califano J
    Cancer Res; 2017 Oct; 77(19):5248-5258. PubMed ID: 28733453
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma.
    Zhong W; Huang C; Lin J; Zhu M; Zhong H; Chiang MH; Chiang HS; Hui MS; Lin Y; Huang J
    Front Genet; 2020; 11():568192. PubMed ID: 33133154
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inhibition of AURKB, regulated by pseudogene
    Guo Y; Wei Q; Tan L; Li Y; Li J; Li L; Jiang T; Zhang S; Jin H
    Am J Cancer Res; 2020; 10(10):3458-3474. PubMed ID: 33163283
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A functional network of gastric-cancer-associated splicing events controlled by dysregulated splicing factors.
    Cheng S; Ray D; Lee RTH; Naripogu KB; Yusoff PABM; Goh PBL; Liu Y; Suzuki Y; Das K; Chan HS; Wong WK; Chan WH; Chow PK; Ong HS; Raj P; Soo KC; Tan P; Epstein DM; Rozen SG
    NAR Genom Bioinform; 2020 Jun; 2(2):lqaa013. PubMed ID: 33575575
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Extensive cryptic splicing upon loss of RBM17 and TDP43 in neurodegeneration models.
    Tan Q; Yalamanchili HK; Park J; De Maio A; Lu HC; Wan YW; White JJ; Bondar VV; Sayegh LS; Liu X; Gao Y; Sillitoe RV; Orr HT; Liu Z; Zoghbi HY
    Hum Mol Genet; 2016 Dec; 25(23):5083-5093. PubMed ID: 28007900
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prognostic implication and functional annotations of APOBEC3G expression in patients with Melanoma.
    Han W; Xu J; Shen GL
    J Cancer; 2020; 11(17):5245-5256. PubMed ID: 32742470
    [No Abstract]   [Full Text] [Related]  

  • 69. Analysis of mTOR Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K-AKT-mTOR Pathway Inhibitors.
    Kong Y; Si L; Li Y; Wu X; Xu X; Dai J; Tang H; Ma M; Chi Z; Sheng X; Cui C; Guo J
    Clin Cancer Res; 2016 Feb; 22(4):1018-27. PubMed ID: 26490311
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A global analysis on the differential regulation of RNA binding proteins (RBPs) by TNF-α as potential modulators of metabolic syndromes.
    Louis JM; Agarwal A; Mondal S; Talukdar I
    BBA Adv; 2022; 2():100037. PubMed ID: 37082594
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Recent advances in functional annotation and prediction of the epitranscriptome.
    Zhang SY; Zhang SW; Zhang T; Fan XN; Meng J
    Comput Struct Biotechnol J; 2021; 19():3015-3026. PubMed ID: 34136099
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Roles and mechanisms of aberrant alternative splicing in melanoma - implications for targeted therapy and immunotherapy resistance.
    Chen W; Geng D; Chen J; Han X; Xie Q; Guo G; Chen X; Zhang W; Tang S; Zhong X
    Cancer Cell Int; 2024 Mar; 24(1):101. PubMed ID: 38462618
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Given dimensions of neoplastic events as aberrantly operative alternative splicing.
    Agius LM
    Patholog Res Int; 2010; 2010():509245. PubMed ID: 21151513
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Publisher Correction: Deciphering DNA variant-associated aberrant splicing with the aid of RNA sequencing.
    Zhang B; Gao X
    Nat Genet; 2023 Jul; 55(7):1251. PubMed ID: 37308788
    [No Abstract]   [Full Text] [Related]  

  • 75. QKI-5 regulates the alternative splicing of cytoskeletal gene ADD3 in lung cancer.
    Wang JZ; Fu X; Fang Z; Liu H; Zong FY; Zhu H; Yu YF; Zhang XY; Wang SF; Huang Y; Hui J
    J Mol Cell Biol; 2021 Aug; 13(5):347-360. PubMed ID: 33196842
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer.
    Xu L; Pan J; Ding Y; Pan H
    Front Genet; 2020; 11():522383. PubMed ID: 33193606
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Construction and validation of an immunity-related prognostic signature for breast cancer.
    Zhu T; Zheng J; Hu S; Zhang W; Zhou H; Li X; Liu ZQ
    Aging (Albany NY); 2020 Nov; 12(21):21597-21612. PubMed ID: 33216733
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification of Alternative Splicing in Proteomes of Human Melanoma Cell Lines without RNA Sequencing Data.
    Lobas AA; Solovyeva EM; Levitsky LI; Goncharov AO; Lyssuk EY; Larin SS; Moshkovskii SA; Gorshkov MV
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768787
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Expression profile and prognostic values of LSM family in skin cutaneous melanoma.
    Sun X; Zhang J; Xiao C; Ge Z
    BMC Med Genomics; 2022 Nov; 15(1):238. PubMed ID: 36371223
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Transcriptome-Wide Isoform Landscape of Melanocytic Nevi and Primary Melanomas Identifies Gene Isoforms Associated with Malignancy.
    Hakobyan S; Loeffler-Wirth H; Arakelyan A; Binder H; Kunz M
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.